We are live on
!
Find out more
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 76 |
LCM
76
Laurion Capital Management
New York
| – | -$880K | -40,000 | Closed |
|
| 77 |
77
HSBC Holdings
London,
United Kingdom
| – | -$256K | -11,620 | Closed |
|
| 78 |
PP
78
Paloma Partners
Greenwich,
Connecticut
| – | -$212K | -9,612 | Closed |
|
| 79 |
TRCT
79
Tower Research Capital (TRC)
New York
| – | -$74K | -3,357 | Closed |
|
| 80 |
80
UBS Group
Zurich,
Switzerland
| – | -$24K | -1,110 | Closed |
|
| 81 |
FMA
81
FNY Managed Accounts
New York
| – | -$9K | -440 | Closed |
|